18 results
8-K
RNXT
RenovoRx Inc
23 Feb 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:00pm
2023, Ms. Gentry served as Senior Vice President of Clinical Development and Operations for Evotec, GmbH. Prior to her tenure at Evotec, Ms. Gentry … tenure with Otsuka, Ms. Gentry held clinical management positions within contract research organizations from 1995 to 2005, including IQVIA, PPD
8-K
EX-99.1
RNXT
RenovoRx Inc
19 Sep 22
RenovoRx Appoints Angela Gill Nelms as Chief Operating Officer
8:45am
countries. Additionally, during her tenure, the company grew from four to over 100 employees. Ms. Nelms earned a Bachelor of Science in Biomedical
DEF 14A
3pmr4nzip jy8
29 Apr 22
Definitive proxy
4:06pm
10-K
8kpvuq
30 Mar 22
Annual report
7:21am
424B4
tsn2jjp yv16ktn
27 Aug 21
Prospectus supplement with pricing info
6:06am
S-1/A
ryt gjnxpn
5 Aug 21
IPO registration (amended)
5:29pm
S-1
EX-3.4
m3sdgoib24 4e6nxw
21 Jul 21
IPO registration
5:15pm
S-1
vn0863fl1ho
21 Jul 21
IPO registration
5:15pm
DRS/A
ehyo98tck7l p9io
15 Jun 21
Draft registration statement (amended)
12:00am
DRS/A
EX-3.3
hli9n1zo28y1raq1
12 May 21
Draft registration statement (amended)
12:00am
DRS/A
vaf 9o3i8fl
12 May 21
Draft registration statement (amended)
12:00am
DRS
dram e3og
2 Apr 21
Draft registration statement
12:00am
- Prev
- 1
- Next